The Global Kidney Function Tests Market was valued at USD 635.80 Million in 2023 and is projected to reach USD 912.80 Million by 2032, growing at a Compound Annual Growth Rate (CAGR) of 4.10% during the forecast period (2023-2032). This growth is driven by rising chronic kidney disease prevalence, increasing diabetic population, and advancements in diagnostic technologies.
As healthcare systems worldwide focus on preventive care and early disease detection, kidney function testing has become a critical diagnostic segment. This report profiles the Top 10 Companies in the Kidney Function Tests Market—global diagnostics leaders and specialized manufacturers driving innovation in renal care diagnostics.
🔟 1. Abbott Laboratories
Headquarters: Abbott Park, Illinois, USA
Key Offering: ARCHITECT Urine Chemistry Analyzers, Alinity ci-series, Point-of-Care Tests
Abbott maintains market leadership with its comprehensive portfolio of automated analyzers and test kits. The company has made significant investments in digital health solutions that integrate kidney function data with patient management platforms.
Technology Leadership:
- FDA-cleared i-STAT handheld creatinine testing platform
- Strategic partnerships for remote patient monitoring solutions
- Automated uACR testing with rapid turnaround times
Download FREE Sample Report: Kidney Function Tests Market – View in Detailed Research Report
9️⃣ 2. F. Hoffmann-La Roche Ltd
Headquarters: Basel, Switzerland
Key Offering: cobas® analyzers, renal biomarker tests, POC diagnostics
Roche Diagnostics offers one of the industry’s most comprehensive kidney function test menus, including creatinine, BUN, cystatin C, and proteinuria detection solutions.
Technology Leadership:
- High-throughput cobas® pro integrated systems
- Novel kidney injury biomarker development programs
- Cloud-based laboratory information management
8️⃣ 3. Siemens Healthineers
Headquarters: Erlangen, Germany
Key Offering: Atellica® Solution, ADVIA Chemistry Systems, urine analyzers
Siemens provides advanced testing solutions across clinical chemistry and urinalysis segments, with automated systems featuring quality control innovations.
Technology Leadership:
- Integrated creatinine/eGFR testing workflows
- AI-powered urine sediment analysis technology
- Digital connectivity solutions for laboratory networks
7️⃣ 4. Thermo Fisher Scientific
Headquarters: Waltham, Massachusetts, USA
Key Offering: Cascadion SM Clinical Analyzer, ELISA kits, mass spectrometry
Thermo Fisher excels in both routine and specialized renal testing, with advanced platforms for biomarker detection and precise measurement.
Technology Leadership:
- LC-MS/MS gold standard creatinine measurement
- Central lab and point-of-care integration capabilities
- Comprehensive renal disease research solutions
Download FREE Sample Report: Kidney Function Tests Market – View in Detailed Research Report
6️⃣ 5. Danaher Corporation (Beckman Coulter)
Headquarters: Washington, D.C., USA
Key Offering: AU Clinical Chemistry Analyzers, DxC Systems
Beckman Coulter’s solutions combine automated chemistry platforms with advanced informatics for comprehensive renal assessment in high-volume labs.
Technology Leadership:
- Automated eGFR calculation algorithms
- Standardized creatinine measurement technology
- Laboratory workflow optimization systems
5️⃣ 6. Sysmex Corporation
Headquarters: Kobe, Japan
Key Offering: UN-Series urine analyzers, UF flow cytometry
Sysmex specializes in urinalysis solutions that provide critical kidney function indicators through digital imaging and AI-powered analysis.
Technology Leadership:
- Automated urine particle classification technology
- Compact point-of-care testing solutions
- Standardized urine sediment reporting
4️⃣ 7. Bio-Rad Laboratories
Headquarters: Hercules, California, USA
Key Offering: Quality control products, Platelia™ assays
Bio-Rad provides essential QC systems while developing novel assays for early renal disease detection and standardized testing.
Technology Leadership:
- Third-party quality assurance programs
- Automated immunoassay platforms
- Standardized albuminuria testing solutions
3️⃣ 8. ARKRAY, Inc.
Headquarters: Kyoto, Japan
Key Offering: PocketChem analyzers, urine chemistry systems
ARKRAY specializes in compact, user-friendly solutions for decentralized testing environments and resource-limited settings.
Technology Leadership:
- Portable creatinine analysis technology
- Dry chemistry solutions for rural applications
- Cost-effective urinalysis platforms
2️⃣ 9. QuidelOrtho Corporation
Headquarters: San Diego, California, USA
Key Offering: Vitros® chemistry systems, microalbumin assays
The merged entity offers comprehensive renal testing solutions from central labs to physician offices, with workflow-efficient platforms.
Technology Leadership:
- Automated albumin/creatinine ratio testing
- Integrated renal health assessment panels
- Rapid screening solutions for CKD
1️⃣ 10. Randox Laboratories
Headquarters: Antrim, United Kingdom
Key Offering: RX series analyzers, quality controls
Randox specializes in innovative testing solutions with emphasis on quality assurance and novel biomarker development.
Technology Leadership:
- Automated urine protein electrophoresis
- Specialized controls for renal markers
- Flexible testing configurations
Get Full Report Here: Kidney Function Tests Market – View in Detailed Research Report
🌍 Outlook: The Future of Kidney Function Diagnostics
The renal diagnostics market is undergoing transformation through digital innovation and the shift toward personalized, preventive healthcare approaches.
📈 Key Market Trends:
- Accelerated adoption of automated, high-throughput testing platforms
- Growth in point-of-care renal testing across clinical settings
- Integration of AI and machine learning in diagnostic interpretation
- Expansion of biomarker panels for comprehensive renal assessment
- Development of home-based testing and remote monitoring solutions
Get Full Report Here: Kidney Function Tests Market – View in Detailed Research Report
The companies profiled are driving the future of renal diagnostics through innovative technologies that enable earlier disease detection, improved monitoring, and better clinical outcomes.